Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.
Hepatitis C virus (HCV) infection is one of the major causes of chronic liver disease worldwide. The critical role of innate as well as adaptive immunity has been reported in HCV persistence and liver injury. In the early phase of acute infection, HCV continues to replicate in the liver, suggesting the HCV capability of inhibiting innate immunity. The sustained, vigorous and multiepitope-specific CD4+ and CD8+ T cell responses are essential for spontaneous HCV clearance. HCV-specific CD8+ T cells are primary elements for HCV clearance by inducing hepatocyte apoptosis, in which Fas/CD95 is fundamentally involved. However, once HCV persistency develops, HCV utilizes multifaceted arms to subvert various immune effectors. During IFNalpha-based therapy, the enhancement of HCV-specific CD4+ T cell response followed by HCV eradication has been reported, however, it remains obscure whether the therapeutic HCV clearance is able to restore the durable immune competency to HCV. Further investigation is still warranted to establish the means to direct HCV-specific immune responses in the desired way.
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka.
Tatsuya
T
Kanto
Norio
N
Hayashi
D000818:Animals; D017951:Antigen Presentation / Q000502:physiology; D020169:Caspases / Q000276:immunology; D002454:Cell Differentiation / Q000502:physiology; D016207:Cytokines / Q000276:immunology; D003713:Dendritic Cells / Q000276:immunology; D053222:Fas Ligand Protein; D016174:Hepacivirus / Q000502:physiology; D006526:Hepatitis C / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000276:immunology*; D022781:Hepatocytes / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular / Q000502:physiology*; D007113:Immunity, Innate; D007694:Killer Cells, Natural / Q000502:physiology; D008099:Liver / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000502:physiology; D051193:Toll-Like Receptors / Q000502:physiology; D048069:Tumor Necrosis Factors / Q000276:immunology; D014779:Virus Replication
D016207:Cytokines; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D051193:Toll-Like Receptors; D048069:Tumor Necrosis Factors; D020169:Caspases